ArticleACS omega2025
Host-Guest Dynamic Behavior of Melatonin Encapsulated in β-Cyclodextrin Nanosponges.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cyclodextrin-based nanosponges are cross-linked polymeric porous nanomaterials obtained by condensation of cyclodextrins with a polyfunctional reagent (cross-linker). Owing to their high surface area, they are attractive for encapsulation applications aimed at increasing the stability, solubility, and bioavailability of drugs. Due to the structural complexity of these emerging materials, computer modeling can provide atomistic-level insights into both the flexibility of nanosponges and their interactions with encapsulated drugs. In this contribution, we focus on nanosponges of β-cyclodextrin cross-linked with citric acid and provide full-atom models for linear and cyclic topologies. We use extensive molecular dynamics (MD) simulations to analyze the flexibility of these constructs and their interactions with encapsulated melatonin, a neurohormone involved in sleep-wake cycle regulation also used as an antioxidant and immunomodulator. We characterize the main interactions responsible for melatonin binding and show that it benefits from multivalence and crowding effects.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.